Stay updated on Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Cosmetic/UI layout changes were observed. Core study details, enrollment numbers, and outcomes remain unchanged.
    Difference
    0.1%
    Check dated 2026-03-27T02:34:37.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added hepatocellular carcinoma to the study's eligible conditions and updated the page to revision v3.5.0 (replacing v3.4.3).
    Difference
    0.2%
    Check dated 2026-03-19T23:52:25.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:31:46.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    No additions or deletions detected; the page content and layout appear unchanged.
    Difference
    0.1%
    Check dated 2026-03-05T18:17:35.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page shows a visual/layout refresh with updated styling and reflowed content blocks. Underlying study details such as eligibility criteria and outcomes remain unchanged.
    Difference
    0.1%
    Check dated 2026-02-26T10:50:09.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2026-02-19T07:20:46.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page.